Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Woodling, Nathan S."'
Autor:
Simone, Roberto, Balendra, Rubika, Moens, Thomas G, Preza, Elisavet, Wilson, Katherine M, Heslegrave, Amanda, Woodling, Nathan S, Niccoli, Teresa, Gilbert‐Jaramillo, Javier, Abdelkarim, Samir, Clayton, Emma L, Clarke, Mica, Konrad, Marie‐Therese, Nicoll, Andrew J, Mitchell, Jamie S, Calvo, Andrea, Chio, Adriano, Houlden, Henry, Polke, James M, Ismail, Mohamed A, Stephens, Chad E, Vo, Tam, Farahat, Abdelbasset A, Wilson, W David, Boykin, David W, Zetterberg, Henrik, Partridge, Linda, Wray, Selina, Parkinson, Gary, Neidle, Stephen, Patani, Rickie, Fratta, Pietro, Isaacs, Adrian M
Publikováno v:
EMBO Molecular Medicine
EMBO Molecular Medicine, Vol 10, Iss 1, Pp 22-31 (2018)
EMBO Molecular Medicine, Vol 10, Iss 1, Pp 22-31 (2018)
Intronic GGGGCC repeat expansions in C9orf72 are the most common known cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), which are characterised by degeneration of cortical and motor neurons, respectively. Repeat expansi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6414c2407183893ea509c0981b6b29a8
http://hdl.handle.net/2318/1663027
http://hdl.handle.net/2318/1663027
Autor:
Mizielinska, Sarah, Ridler, Charlotte E., Balendra, Rubika, Thoeng, Annora, Woodling, Nathan S., Grässer, Friedrich A., Plagnol, Vincent, Lashley, Tammaryn, Partridge, Linda, Isaacs, Adrian M.
Publikováno v:
Acta Neuropathol Commun
Acta Neuropathologica Communications, Vol 5, Iss 1, Pp 1-11 (2017)
Mizielinska, S, Ridler, C E, Balendra, R, Thoeng, A, Woodling, N S, Grässer, F A, Plagnol, V, Lashley, T, Partridge, L & Isaacs, A M 2017, ' Bidirectional nucleolar dysfunction in C9orf72 frontotemporal lobar degeneration ', Acta Neuropathologica Communications, vol. 5, no. 1, 29 . https://doi.org/10.1186/s40478-017-0432-x
Acta Neuropathologica Communications
Acta Neuropathologica Communications, Vol 5, Iss 1, Pp 1-11 (2017)
Mizielinska, S, Ridler, C E, Balendra, R, Thoeng, A, Woodling, N S, Grässer, F A, Plagnol, V, Lashley, T, Partridge, L & Isaacs, A M 2017, ' Bidirectional nucleolar dysfunction in C9orf72 frontotemporal lobar degeneration ', Acta Neuropathologica Communications, vol. 5, no. 1, 29 . https://doi.org/10.1186/s40478-017-0432-x
Acta Neuropathologica Communications
An intronic GGGGCC expansion in C9orf72 is the most common known cause of both frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). The repeat expansion leads to the generation of sense and antisense repeat RNA aggregates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8cffffc8c9dbf8d06df8f513631ba9ec
https://hdl.handle.net/21.11116/0000-000B-4F59-A
https://hdl.handle.net/21.11116/0000-000B-4F59-A
Autor:
Simone, Roberto, Balendra, Rubika, Moens, Thomas G., Preza, Elisavet, Wilson, Katherine M., Heslegrave, Amanda, Woodling, Nathan S., Niccoli, Teresa, Gilbert‐Jaramillo, Javier, Abdelkarim, Samir, Clayton, Emma L., Clarke, Mica, Konrad, Marie‐Therese, Nicoll, Andrew J., Mitchell, Jamie S., Calvo, Andrea, Chio, Adriano, Houlden, Henry, Polke, James M., Ismail, Mohamed A.
Publikováno v:
EMBO Molecular Medicine; Jan2018, Vol. 10 Issue 1, p22-31, 10p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Grant, Jacqueline L., Bou Ghosn, Eliver Eid, Axtell, Robert C., Herges, Katja, Kuipers, Hedwich F., Woodling, Nathan S., Andreasson, Katrin, Herzenberg, Leonard A., Herzenberg, Leonore A., Steinman, Lawrence
Publikováno v:
Science Translational Medicine; 8/1/2012, Vol. 4 Issue 145, preceding p1-12, 13p
Autor:
Grant, Jacqueline L., Ghosn, Eliver Eid Bou, Axtell, Robert C., Herges, Katja, Kuipers, Hedwich F., Woodling, Nathan S., Andreasson, Katrin, Herzenberg, Leonard A., Herzenberg, Leonore A., Steinman, Lawrence
Publikováno v:
Science Translational Medicine; August 2012, Vol. 4 Issue: 145 p145ra105-145ra105, 1p
Autor:
Simone R; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Balendra R; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.; Department of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, London, UK., Moens TG; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.; Department of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, London, UK., Preza E; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK., Wilson KM; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Heslegrave A; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK., Woodling NS; Department of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, London, UK., Niccoli T; Department of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, London, UK., Gilbert-Jaramillo J; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Abdelkarim S; MRC Centre for Neuromuscular Disease UCL Institute of Neurology, London, UK., Clayton EL; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Clarke M; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Konrad MT; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Nicoll AJ; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.; MRC Prion Unit at UCL Institute of Prion Diseases, London, UK., Mitchell JS; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Calvo A; 'Rita Levi Montalcini' Department of Neuroscience, ALS Centre University of Turin, Turin, Italy., Chio A; 'Rita Levi Montalcini' Department of Neuroscience, ALS Centre University of Turin, Turin, Italy., Houlden H; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK., Polke JM; Neurogenetics Unit UCL Institute of Neurology, London, UK., Ismail MA; Department of Chemistry, Georgia State University, Atlanta, GA, USA., Stephens CE; Department of Chemistry, Georgia State University, Atlanta, GA, USA., Vo T; Department of Chemistry, Georgia State University, Atlanta, GA, USA., Farahat AA; Department of Chemistry, Georgia State University, Atlanta, GA, USA., Wilson WD; Department of Chemistry, Georgia State University, Atlanta, GA, USA., Boykin DW; Department of Chemistry, Georgia State University, Atlanta, GA, USA., Zetterberg H; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.; Clinical Neurochemistry Laboratory Institute of Neuroscience and Physiology Department of Psychiatry and Neurochemistry The Sahlgrenska Academy University of Gothenburg, Gothenburg, Sweden.; UK Dementia Research Institute at UCL UCL Institute of Neurology, London, UK., Partridge L; Department of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, London, UK.; Max Planck Institute for Biology of Ageing, Cologne, Germany., Wray S; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK., Parkinson G; UCL School of Pharmacy, London, UK., Neidle S; UCL School of Pharmacy, London, UK s.neidle@ucl.ac.uk rickie.patani@ucl.ac.uk p.fratta@ucl.ac.uk a.isaacs@ucl.ac.uk., Patani R; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK s.neidle@ucl.ac.uk rickie.patani@ucl.ac.uk p.fratta@ucl.ac.uk a.isaacs@ucl.ac.uk., Fratta P; MRC Centre for Neuromuscular Disease UCL Institute of Neurology, London, UK s.neidle@ucl.ac.uk rickie.patani@ucl.ac.uk p.fratta@ucl.ac.uk a.isaacs@ucl.ac.uk., Isaacs AM; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK s.neidle@ucl.ac.uk rickie.patani@ucl.ac.uk p.fratta@ucl.ac.uk a.isaacs@ucl.ac.uk.; UK Dementia Research Institute at UCL UCL Institute of Neurology, London, UK.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2018 Jan; Vol. 10 (1), pp. 22-31.
Autor:
Mizielinska S; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.; Maurice Wohl Clinical Neuroscience Institute, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, SE5 9RT, UK., Ridler CE; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK., Balendra R; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.; Department of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, Darwin Building, Gower Street, London, WC1E 6BT, UK., Thoeng A; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK., Woodling NS; Department of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, Darwin Building, Gower Street, London, WC1E 6BT, UK., Grässer FA; Institute of Virology, Saarland University Medical School, 66421, Hamburg, Germany., Plagnol V; UCL Genetics Institute, University College London, London, WC1E 6BT, UK., Lashley T; Department of Molecular Neuroscience, Queen Square Brain Bank, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK., Partridge L; Department of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, Darwin Building, Gower Street, London, WC1E 6BT, UK.; Max Planck Institute for Biology of Ageing, Joseph-Stelzmann-Strasse 9b, 50931, Cologne, Germany., Isaacs AM; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. a.isaacs@ucl.ac.uk.
Publikováno v:
Acta neuropathologica communications [Acta Neuropathol Commun] 2017 Apr 18; Vol. 5 (1), pp. 29. Date of Electronic Publication: 2017 Apr 18.